Roca Therapeutics closed a funding round (amount undisclosed) in Sep 2022. The company is based in Nice, France. Investors in the round: BPI, Eurobiomed Grand Sud, PACA Cancéropôle and 2 others. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
